Patents by Inventor Blake MANDELL

Blake MANDELL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20260199286
    Abstract: The invention relates to psychoactive medicines including methylone, 2C-B, MBDB, their respective salts, metabolites, isomers, enantiomers, solvates, isotopologues and isotopomers, polymorphs, prodrugs and analogs (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: December 10, 2025
    Publication date: July 16, 2026
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT, Markus SEELIG
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20260130884
    Abstract: The invention relates to psychoactive medicines including methylone, 2C-B, MBDB, their respective salts, metabolites, isomers, enantiomers, solvates, isotopologues and isotopomers, polymorphs, prodrugs and analogs (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: December 10, 2025
    Publication date: May 14, 2026
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT, Markus SEELIG
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20260083699
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: December 4, 2025
    Publication date: March 26, 2026
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT, Markus SEELIG
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20250332139
    Abstract: The invention relates to psychoactive medicines including methylone, 2C-B, MBDB, their respective salts, metabolites, isomers, enantiomers, solvates, isotopologues and isotopomers, polymorphs, prodrugs and analogs (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: May 8, 2025
    Publication date: October 30, 2025
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT, Markus SEELIG
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20250255846
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: January 16, 2025
    Publication date: August 14, 2025
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20250221957
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: February 2, 2023
    Publication date: July 10, 2025
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT, Markus SEELIG
  • Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
    Patent number: 12343326
    Abstract: The invention relates to psychoactive medicines including methylone, 2C-B, MBDB, their respective salts, metabolites, isomers, enantiomers, solvates, isotopologues and isotopomers, polymorphs, prodrugs and analogs (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Grant
    Filed: July 25, 2024
    Date of Patent: July 1, 2025
    Assignee: TRANSCEND THERAPEUTICS, INC.
    Inventors: Blake Mandell, Martin Stogniew, Jennifer Louise Schmidt
  • Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
    Patent number: 12295937
    Abstract: The invention relates to psychoactive medicines including methylone, 2C-B, MBDB, their respective salts, metabolites, isomers, enantiomers, solvates, isotopologues and isotopomers, polymorphs, prodrugs and analogs (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Grant
    Filed: July 31, 2024
    Date of Patent: May 13, 2025
    Assignee: TRANSCEND THERAPEUTICS, INC.
    Inventors: Blake Mandell, Martin Stogniew, Jennifer Louise Schmidt, Markus Seelig
  • Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
    Patent number: 12233046
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Grant
    Filed: May 9, 2024
    Date of Patent: February 25, 2025
    Assignee: TRANSCEND THERAPEUTICS, INC.
    Inventors: Blake Mandell, Martin Stogniew, Jennifer Louise Schmidt
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20250009711
    Abstract: The invention relates to psychoactive medicines including methylone, 2C-B, MBDB, their respective salts, metabolites, isomers, enantiomers, solvates, isotopologues and isotopomers, polymorphs, prodrugs and analogs (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: July 25, 2024
    Publication date: January 9, 2025
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20240390322
    Abstract: The invention relates to psychoactive medicines including methylone, 2C-B, MBDB, their respective salts, metabolites, isomers, enantiomers, solvates, isotopologues and isotopomers, polymorphs, prodrugs and analogs (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: July 31, 2024
    Publication date: November 28, 2024
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT, Markus SEELIG
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20240293357
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: May 9, 2024
    Publication date: September 5, 2024
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT, Markus SEELIG
  • Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
    Patent number: 12059402
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Grant
    Filed: June 28, 2023
    Date of Patent: August 13, 2024
    Assignee: TRANSCEND THERAPEUTICS, INC.
    Inventors: Blake Mandell, Martin Stogniew, Jennifer Louise Schmidt, Markus Seelig
  • Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
    Patent number: 11969407
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Grant
    Filed: November 2, 2023
    Date of Patent: April 30, 2024
    Assignee: TRANSCEND THERAPEUTICS, INC.
    Inventors: Blake Mandell, Martin Stogniew, Jennifer Louise Schmidt, Markus Seelig
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20240058301
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: November 2, 2023
    Publication date: February 22, 2024
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT, Markus SEELIG
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20230338333
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: June 28, 2023
    Publication date: October 26, 2023
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin Stogniew, Jennifer Louise Schmidt, Markus Seelig
  • Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
    Patent number: 11707446
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: July 25, 2023
    Assignee: TRANSCEND THERAPEUTICS, INC.
    Inventors: Blake Mandell, Martin Stogniew, Jennifer Louise Schmidt, Markus Seelig
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20230054211
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: August 15, 2022
    Publication date: February 23, 2023
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT, Markus SEELIG